等待開盤 06-25 09:30:00 美东时间
+2.430
+0.53%
新思科技(Synopsys)受益于设计IP业务复苏、半导体行业复杂度提升的双重驱动,正进入长期稳定增长通道,其设计IP业务营收占总营收的25%。 核心支撑因素包...
今天 00:23
新思科技当前核心矛盾为实际盈利表现强于看空者预期,但TTM市盈率达105.37倍,估值缺乏足够业绩支撑,股价经累计下跌34.92%后报464.58美元,接近5...
06-24 19:18
今日重点评级关注:摩根士丹利:维持杜邦"标配"评级,目标价从52美元升至156美元;蒙特利尔银行:维持Taysha Gene Therapies"跑赢大市"评级,目标价从10美元升至14美元
06-24 14:08
核心事件:本次针对半导体AI资本支出红利下的两大标的新思科技(SNPS)、Applied Digital(APLD)展开基本面梳理,对比二者投资逻辑、业绩、估值...
06-24 00:20
核心事件:新思科技(SNPS)当日股价大涨2.78%,收报477.50美元,日内最高触及479.80美元,突破475美元关键心理关口,接近当日高位收盘,行情为超...
06-23 22:27
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. B of A Securities raised the price target for Micron Technology Inc (NASDAQ:MU) from $950 to $1,500. B of A Se...
06-23 21:08
Piper Sandler analyst Clarke Jeffries upgrades Synopsys (NASDAQ:SNPS) from Neutral to Overweight and raises the price target from $450 to $550.
06-23 17:07
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys June 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apogee Therapeutics, GE Healthcare and Synopsys on Tuesday. HIGHLIGHTS * Apogee Therapeutics Inc
06-23 15:27
核心事件:新思科技(SNPS)当前股价回调被判定更倾向于估值重估,而非核心成长逻辑破位。 关键数据指标: 当前收盘价454.38美元,较52周高点651....
06-23 03:11
Insiders have been trading these 5 stocks: (($SNPS)), (($RDDT)), (($ADSK)), (($...
06-20 21:01